Yanrong Li Selected Research

Yanrong Li Research Topics

Disease

10	Neoplasms (Cancer) 03/2024 - 01/2018
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2024 - 01/2013
4	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 01/2020
3	Cognitive Dysfunction 10/2021 - 01/2019
3	Infections 01/2018 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 02/2020
2	Inflammation (Inflammations) 01/2023 - 12/2014
2	Fatty Liver 01/2022 - 12/2014
2	Hypoxia (Hypoxemia) 01/2022 - 11/2020
2	Dementia (Dementias) 01/2020 - 01/2019
2	Glaucoma 11/2018 - 11/2017
1	Stomach Neoplasms (Stomach Cancer) 03/2024
1	Chronic Renal Insufficiency 12/2023
1	Myocardial Infarction 12/2023
1	Neural Tube Defects (Exencephaly) 08/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Insulin Resistance 01/2023
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	Hypercapnia 12/2022
1	Hypocapnia 12/2022
1	Tension-Type Headache (Tension Headache) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Headache (Headaches) 01/2022
1	Parkinson Disease (Parkinson's Disease) 12/2021
1	Reperfusion Injury 08/2021
1	Brain Ischemia (Cerebral Ischemia) 08/2021
1	Cerebral Small Vessel Diseases 01/2021
1	Vascular System Injuries 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 06/2020
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2020
1	Pain (Aches) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020
1	Glioma (Gliomas) 12/2019
1	Communicable Diseases (Infectious Diseases) 11/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Ulcerative Colitis 01/2018
1	Colitis 01/2018
1	Stomach Ulcer (Gastric Ulcer) 01/2018

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 12/2023 - 12/2014
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2017
4	InflammasomesIBA 01/2023 - 08/2021
2	Neutral Amino AcidsIBA 03/2024 - 02/2024
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2022
2	CytokinesIBA 01/2022 - 11/2019
2	NLR ProteinsIBA 01/2022 - 08/2021
2	Retinaldehyde (Retinal)IBA 01/2022 - 11/2020
2	Oxygen (Dioxygen)IBA 01/2022 - 11/2020
2	Timolol (Blocadren)FDA LinkGeneric 11/2018 - 11/2017
2	NF-kappa B (NF-kB)IBA 01/2018 - 01/2018
1	Caspase 3 (Caspase-3)IBA 03/2024
1	Cisplatin (Platino)FDA LinkGeneric 03/2024
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2024
1	tanshinoneIBA 03/2024
1	CreatinineIBA 12/2023
1	Troponin T (Troponin T1)IBA 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2023
1	PlatinumIBA 09/2023
1	wuzi yanzongIBA 08/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Type A Botulinum Toxins (Botox)FDA Link 01/2022
1	NADPH Oxidase 4IBA 01/2022
1	Huang QiIBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2022
1	hyperosideIBA 12/2021
1	oridoninIBA 08/2021
1	Heme (Haem)IBA 11/2020
1	CaspasesIBA 11/2020
1	HesperidinIBA 11/2020
1	AntibodiesIBA 06/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2020
1	lenvatinibIBA 06/2020
1	Immune Checkpoint InhibitorsIBA 06/2020
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 06/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	CrizotinibIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Sevoflurane (Ultane)FDA LinkGeneric 12/2019
1	Small Interfering RNA (siRNA)IBA 12/2019
1	Anesthetics (Anesthetic Agents)IBA 12/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	Apolipoprotein E4IBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	VemurafenibIBA 01/2019
1	Ophthalmic Solutions (Eye Drops)IBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2018
1	Emodin (Archin)IBA 01/2018
1	1-Deoxynojirimycin (1 Deoxynojirimycin)IBA 01/2018
1	Cell Cycle ProteinsIBA 01/2018

Therapy/Procedure

6	Therapeutics 03/2024 - 09/2017
1	Transplantation 01/2024
1	Breathing Exercises 12/2022
1	Punctures 01/2022
1	Oral Administration 01/2018